Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC

NCT05974007 · clinicaltrials.gov ↗

RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Neoadjuvant immunochemotherapy
DRUG: Neoadjuvant chemotherapy

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences